drug research News
-
Accelerating Peptide Drug Research with Creative Peptides’ Premade Peptide Library
New York, United States—April 21, 2022—Total peptide library construction is a powerful technology for new drug research and development at current. As a pioneering peptide company, Creative Peptides developed a total peptide library based on its proprietary peptide design platform, which allows researchers to develop peptide drugs most efficiently. Total peptide library refers to a collection of ...
-
Creative BioMart Updated Its Protein Engineering Rational Design Services
Creative BioMart, a leading customer-centric biotechnology company that is currently developing the potential based on protein engineering technology, recently updated its protein engineering rational design services to help scientists solve problems encountered in their projects. The knowledge of protein structure-function relationships is improved by proteins created through rational design, ...
-
NanoTemper Technologies teams up with PharmAI to help researchers spot game-changing drug candidates from millions of possibilities
PharmAI announced a partnership with NanoTemper Technologies, the most innovative producer of biophysical characterization devices. Together, they will zero in on one of the biggest roadblocks to quick drug development: Researchers have to comb through large amounts of data to find the right drug candidates. This process is an innovation killer, making it difficult for small laboratories to do ...
By PharmAI GmbH
-
Gene Construction Kit & Gene Inspector Compatible with Windows 8
Textco BioSoftware, Inc. today confirmed compatibility with the new Windows® 8 operating system. The current version of Gene Construction Kit® (v 4.0) and Gene Inspector® (v 2.0) are supported under this first Windows 8 release. Minimum system requirements (for both Windows and Macintosh) can be found below: Windows Intel compatible Pentium class processor Windows 8, 7, Vista or ...
-
CD Formulation Enriches Its Supply of Active Pharmaceutical Ingredient Excipients
Continuing to be a trust-worthy CRO company for drug formulation and development, CD Formulation recently announces the enrichment of its active pharmaceutical ingredient excipient offerings. Now a number of API excipients are readily obtainable at CD Formulation, including Cetrorelix Acetate, Fondaparinux Sodium, Calcitriol, Vitamine D3, Tirofiban Hydrochloride, Eptifibatide, Ferric Ammonium ...
-
Natalie Dakers: Chair of Augurex’s Board of Directors Receives 2019 Milton Wong Award
Ms. Dakers began her career in Life Sciences at the University of British Columbia, managing technology transfer for the University Industry Liaison Office (UILO) where she was involved in the creation and spin-off of more than a dozen start-up high-tech and biotech companies. She then went on to co-found NeuroMed Technologies Inc., a private biotechnology company developing drugs for pain, ...
-
Huateng Pharma Launches Exciting New Product Line - Fexuprazan and Vonoprazan Intermediates
Huateng Pharma, a leading innovator in pharmaceutical intermediates, is proud to announce the introduction of its latest product line - Gastrointestinal API Intermediates, featuring the groundbreaking compounds Fexuprazan and Vonoprazan Intermediates. These cutting-edge substances have been meticulously developed to meet the growing demands of the pharmaceutical industry. Fexuprazan Intermediates ...
-
CD Formulation Launches API Chemical Modification Services to Address Drug Solubility, Bioavailability, and Dissolution Rate Issues
Having abundant expertise in drug formulation and pharmaceutical preparation, the New York-based CRO company CD Formulation recently announces that it is now capable of conducting a wide range of API chemical modification services, including pH modification drug molecular service, drug salt formation service, drug pegylation service, and different groups of precursor drug design service, to help ...
-
Longenesis joins Salto Growth Camp: EMERGEncy, a 100-hour online accelerator to address the COVID-19 crisis
Throughout this week Longenesis will be intensively working with mentors and investors (including Skype and Bolt co-Founders) to create and validate a concept for post-COVID-19 data utilization for research, faster drug development and patient recruitment. We believe that the tools developed by Longenesis have found a perfect fit in solving challenges in data and patient cohort identification ...
By Longenesis
-
Revolutionize Your Drug Preformulation Workflows with the Precellys Evolution Homogenizer!
In a recent study in the European Journal of Pharmaceutics and Biopharmaceutics, Jochem Alsenz and Elisabeth Haenel present Precellys® Evolution homogenizer with Cryolys Evolution, a patent cooling system, as a versatile tool for improving preformulation processes in drug development. The study highlights the various uses of Precellys® Evolution homogenizer with Cryolys Evolution, ...
-
Alfa Chemistry Leads the Way in Tailored Preclinical Drug Research Solutions
Alfa Chemistry serves as an emerging pharmaceutical research organization with a mission to revolutionize the field of preclinical drug research with its wide range of comprehensive services. With a commitment to quality and excellence, Alfa Chemistry offers pharmacological analysis, drug safety evaluation, pharmacokinetic analysis, and bioanalytical services to streamline the drug development ...
-
CD ComputaBio Has Launched Hybrid Method for Virtual Screening Service to Assist Scientists
Earlier this month, CD ComputaBio, a senior US provider of computational biology services, announced that it had expanded its service line by providing hybrid method for virtual screening service to customers around the world. Since its establishment, CD ComputaBio has been committed to providing high-quality and all-round services for scientists and researchers to help them make rapid ...
-
Workshop on Bioanalysis to be Held by FDA
On June 30, 2020, from 9:00 a.m. to 5:30 p.m. (EDT),the U.S. Food and Drug Administration (FDA) will host a free regulatory training for industry on bioanalysis requirements and expectations. Focused on how FDA’s Center for Drug Evaluation and Research (CDER) approaches various issues in bioanalysis, the workshop aims to provide participants with a better understanding of how FDA performs ...
-
RDD 2012 Arizona – Respiratory Drug Delivery
Westech Scientific Instruments (Westech) exhibits new instruments at RDD 2012 conference in Phoenix, AZ displaying a range of NEW cascade impactors, flow controllers and related accessories. Westech continues to participate and to introduce new products significant to inhalation drug research and the device testing industries. Westech 7-Stage Cascade Impactor with Micro-Orifice Collector (USP ...
-
CD ComputaBio Announces PD-L1 Targeting Service for Anticancer Drug Research
CD ComputaBio, a reliable computational biology service provider located in New York, is always hammering away at research and trials in order to provide customers with access to the latest software, technologies, and expertise at a competitive price and fast turnaround time. The company recently announced the launch of PD-L1 targeting service for cancer research. Over the past decade, ...
-
CD Bioparticles Launches Dendrons for Drug Delivery Research
CD Bioparticles, a leading manufacturer and supplier of various drug delivery products and services, now introduces a series of dendrons products to support drug delivery research, such as DMPA-G1-Acetylene-NHBOC, DMPA-G1-Azide-NHBoc, and DMPA-G1-Biotin-Carboxyl. They can be used in theranostics, biosensors, optics, adhesives and coatings. CD Bioparticles has expanded its product offering, and ...
-
Peer reviewed publications reporting the effectiveness of the Kurve intranasal insulin product
Nasaldrugdeliveryblog.com opens lines of communication between drug delivery researchers, device manufacturers. The first blog to address issues related to nasal drug delivery formulation, research, delivery, and devices was launched by Kurve Technology, Inc., a leading developer of nasal drug delivery devices. The blog - http://www.nasaldrugdeliveryblog.com - invites scientists, researchers ...
-
NanoTemper Technologies and PharmAI launch Proto, a free AI tool to quickly determine which protein labeling strategy works best for molecular interaction measurements
NanoTemper Technologies, in partnership with PharmAI, announced the launch of Proto, a free AI-based web application that reveals the best labeling strategy to help scientists more efficiently measure molecular interactions, a process that’s necessary to discover and develop new drugs. Proto is one the first commercial applications using the AlphaFold protein structure database that was ...
By PharmAI GmbH
-
CD ComputaBio: A New Provider of Molecular Dynamics Simulation Service
CD ComputaBio is a well-known professional provider of computational biology services in the world, who has a senior research team and advanced experimental instruments. Last week, this company announced that it would introduce molecular dynamics simulation service to all scientists and researchers who want to accelerate drug research and development. This announcement marks the further ...
-
Newly founded research group uses AP-MS to reveal drug targets for Covid-19
QCRG, a newly formed research team, is a collaborative effort between 22 research labs from the University of California, San Francisco, consisting of researchers investigating Covid-19. In a recent proteomics study, the team used affinity purification–mass spectrometry (AP-MS) to uncover new insights into effective molecular targeting. Covid-19 Covid-19 is a respiratory disease caused by ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you